Table 3.
ID | NES | P-value | p.adjust | FDR |
---|---|---|---|---|
HALLMARK_ALLOGRAFT_REJECTION | 1.628 | 0.001 | 0.004 | 0.002 |
HALLMARK_COMPLEMENT | 1.461 | 0.001 | 0.004 | 0.002 |
HALLMARK_E2F_TARGETS | 1.986 | 0.001 | 0.004 | 0.002 |
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 2.013 | 0.001 | 0.004 | 0.002 |
HALLMARK_G2M_CHECKPOINT | 2.042 | 0.001 | 0.004 | 0.002 |
HALLMARK_HYPOXIA | 1.467 | 0.001 | 0.004 | 0.002 |
HALLMARK_INFLAMMATORY_RESPONSE | 1.576 | 0.001 | 0.004 | 0.002 |
HALLMARK_INTERFERON_GAMMA_RESPONSE | 1.763 | 0.001 | 0.004 | 0.002 |
HALLMARK_MYC_TARGETS_V1 | 1.470 | 0.001 | 0.004 | 0.002 |
HALLMARK_TNFA_SIGNALING_VIA_NFKB | 1.641 | 0.001 | 0.004 | 0.002 |
HALLMARK_APOPTOSIS | 1.482 | 0.001 | 0.004 | 0.002 |
HALLMARK_COAGULATION | 1.600 | 0.001 | 0.004 | 0.002 |
HALLMARK_INTERFERON_ALPHA_RESPONSE | 1.670 | 0.001 | 0.004 | 0.002 |
HALLMARK_IL6_JAK_STAT3_SIGNALING | 1.710 | 0.001 | 0.004 | 0.002 |
HALLMARK_ANGIOGENESIS | 1.929 | 0.001 | 0.004 | 0.002 |
HALLMARK_GLYCOLYSIS | 1.436 | 0.002 | 0.006 | 0.004 |
HALLMARK_KRAS_SIGNALING_UP | 1.387 | 0.002 | 0.006 | 0.004 |
HALLMARK_MITOTIC_SPINDLE | 1.364 | 0.003 | 0.008 | 0.005 |
GSEA, gene set enrichment analysis; NES, normalized enrichment score; FDR, false discovery rate.